Association between phenotypic resistance and virologic response to mega-HAART regimen in patients f...
This presentation is the property of its rightful owner.
Sponsored Links
1 / 11

Association between phenotypic resistance and virologic response to mega-HAART regimen in patients from the Frankfurt HIV Cohort PowerPoint PPT Presentation


  • 91 Views
  • Uploaded on
  • Presentation posted in: General

Association between phenotypic resistance and virologic response to mega-HAART regimen in patients from the Frankfurt HIV Cohort. V Miller, A Cozzi-Lepri, K Hertogs, P Gute, B Larder, S Bloor, C Rottmann, AN Phillips, S Staszewski. Introduction.

Download Presentation

Association between phenotypic resistance and virologic response to mega-HAART regimen in patients from the Frankfurt HIV Cohort

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Association between phenotypic resistance and virologic response to mega haart regimen in patients from the frankfurt hi

Association between phenotypic resistance and virologic response to mega-HAART regimen in patients from the Frankfurt HIV Cohort

V Miller, A Cozzi-Lepri, K Hertogs,

P Gute, B Larder, S Bloor,

C Rottmann, AN Phillips, S Staszewski


Introduction

Introduction

  • The Frankfurt HIV Cohort consists of all patients attending the clinic who have presented at least once since Jan 1, 1995

  • data pertaining to antiretroviral history, immune status, HIV-1 viral load, HIV-associated clinical events and demographics are collected prospectively

  • patients with multiple treatment failures were treated with salvage regimen consisting of 6 or more antiretroviral drugs

  • phenotypic resistance tests were performed from stored plasma samples


Patients methods

Patients & Methods

  • 50 patients met the definition criteria and the DAP requirements

  • viral load: Amplicor

  • resistance: Antivirogram (recombinant virus based phenotypic assay)

  • virologic failure: > 400 copies/week 24 window

  • statistical analysis: as described per DAP


Study population baseline characteristics

Study Population: Baseline characteristics

Characteristic Median Range

HIV RNA(log10 copies/ml) 5.52 3.40 - 6.70

CD4 cell count (cells/mm3) 95 2 - 587

Time on HAART (months) 18.3 1.7-53.5


Summary of previous art

Summary of previous ART


Susceptibility status at baseline

Susceptibility Status at Baseline


On treatment drugs

On - Treatment Drugs


Univariate analysis odds ratio of virological failure

Univariate Analysis: Odds ratio of virological failure

DAFDAC

NRTI sens/10

new drugs

NRTI sens/4

PI sens/10

PI sens 4

sens/10

sens/4

RNA


Multivariate analysis odds ratio of virological failure

Multivariate Analysis: Odds ratio of virological failure

DAFDAC

Multivariate 1

Multivariate 2

RNA New Drugs Sens/4

RNA New Drugs Sens/10


Multivariate analysis odds ratio of virological failure1

Multivariate Analysis: Odds ratio of virological failure

DAF DAC

Multivariate 3

Multivariate 4

RNA New Drugs NRTI Sens/4 PI Sens/4

RNA New Drugs NRTI Sens/10 PI Sens 10


Conclusion

Conclusion

  • in this retrospective analysis based on a small group of extensively experienced patients, phenotypic resistance was a significant predictor of virologic response, independent of baseline viral load and previous antiretroviral history

    • either a 4-fold or a 10-fold cut-off provided significant independent information

  • in models looking at resistance within individual drug classes, resistance to PI was more predictive than resistance to NRTI


  • Login